The prevalence of objectively measurable disease in phase III trials of metastatic castration-resistant prostate cancer (mCRPC).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ankit Madan, Mary K Baker, Jori E May, Gurudatta Naik, Sejong Bae, Guru Sonpavde
Institutions: University of Alabama, University of Alabama at Birmingham
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591181744